Mighty mice: Transgenic technology “knocks out” questions of matrix metalloproteinase function
- 31 March 1997
- journal article
- review article
- Published by Elsevier in Matrix Biology
- Vol. 15 (8-9) , 527-533
- https://doi.org/10.1016/s0945-053x(97)90027-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Matrix Metalloproteinases and Cardiovascular DiseaseCirculation Research, 1995
- Collagenase Expression in Transgenic Mouse Skin Causes Hyperkeratosis and Acanthosis and Increases Susceptibility to TumorigenesisMolecular and Cellular Biology, 1995
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.Journal of Clinical Investigation, 1994
- Matrix Metalloproteinases and Their Inhibitors in Tumor ProgressionaAnnals of the New York Academy of Sciences, 1994
- Knockout Mice: Round TwoScience, 1994
- Deletion of a DNA Polymerase β Gene Segment in T Cells Using Cell Type-Specific Gene TargetingScience, 1994
- Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cellsCell, 1994
- Gene knockouts of c-src, transforming growth factor beta 1, and tenascin suggest superfluous, nonfunctional expression of proteins.The Journal of cell biology, 1993
- Matrix Metalloproteinases: A ReviewCritical Reviews in Oral Biology & Medicine, 1993
- Collagenase expression in the lungs of transgenic mice causes pulmonary emphysemaCell, 1992